Cancer mortality
Annual update to 2024
Accredited official statistics
About this release
This release by Public Health Scotland (PHS) provides information on deaths from cancer in Scotland, including registrations up to the 31 December 2024. Within this publication, data is provided on both the number of deaths caused by cancer (excluding non-melanoma skin cancer) and the overall risk of dying from the disease within a population.
Main points
- In 2024 the European Age Standardised Rate (EASR), or risk of dying from cancer in Scotland, decreased by 12.1% compared to 2015 (from 328.5 to 288.9 per 100,000 population respectively).
- However, despite this reduction, the number of deaths due to cancer has increased by 2.1% (to 16,352 from 16,011 in 2015). This largely reflects an increase in the proportion of older age groups within the population, and the fact that cancer is more common among older people.
- In 2024, two-thirds (70%) of all cancer deaths occurred in people aged seventy and over, an increase from 66% in 2015.
- The average age at death increased between 2000 and 2024, rising from 70.9 to 74.4 years for males, and from 72.4 to 74.2 for females. This shift reflects changes towards types of cancers that are diagnosed at older ages, and better survival as a result of earlier cancer detection, more effective treatment and improvements in overall life expectancy.
- Lung, colorectal (bowel), prostate and breast cancers together account for 46% of all cancer deaths in Scotland.
- Lung cancer remained the most common cause of cancer death overall; 3,651 in 2024 (EASR of 62.8 per 100,000 population, accounting for a fifth (22.3%) of all cancer deaths in Scotland. Most of these could be avoided by eliminating smoking.
Background
This publication uses death registration data supplied by National Records of Scotland (NRS). This release includes summary tables presenting information by cancer type, age group, sex, Regional Cancer Network, NHS Board, and local authority. When using this publication, it is more informative to examine trends in mortality over a number of years, rather than focussing on a single year of mortality. In the case of rare cancers, striking changes from one year to the next are likely to reflect random fluctuation caused by small numbers of deaths and may be misleading.
Further information
The next release of this publication will be Winter 2026.
General enquiries
If you have an enquiry relating to this publication, please email phs.cancerstats@phs.scot.
Media enquiries
If you have a media enquiry relating to this publication, please contact the Communications and Engagement team.
Requesting other formats and reporting issues
If you require publications or documents in other formats, please email phs.otherformats@phs.scot.
To report any issues with a publication, please email phs.generalpublications@phs.scot.
Older versions of this publication
Versions of this publication released before 16 March 2020 may be found on the Data and Intelligence, Health Protection Scotland or Improving Health websites.
